Stock itci.

Intra-Cellular Therapies (ITCI) Stock Forecast, Price Targets and ...Nov 20, 2023 · Shares of ITCI responded in kind, rallying 16% in the subsequent trading session and ultimately 40% higher to an all-time high of $67.05 in June 2023, suggesting peak sales of $1.75 billion to $2. ... Intra-Cellular Therapies (ITCI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.Earnings for Intra-Cellular Therapies are expected to grow in the coming year, from ($1.68) to ($0.80) per share. Intra-Cellular Therapies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 6th, 2024 based off prior year's report dates. Read More.

NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the 2023 Cantor Fitzgerald Global Healthcare Conference on Wednesday, …home / stock / itci / itci news. RSS . ITCI ITCI Quote ITCI Short ITCI News ITCI Articles ITCI Message Board. March, 09 2021 08:51 AM | Financial News Media | More on ITCI. ITCI; ITCI Quote; ... (NASDAQ:ITCI), and Pfizer Inc. (NYSE:PFE) are helping to make this change happen. Numinus Wellness Shares Promising Developments .The average Intra Cellular Therapies stock price prediction forecasts a potential upside of 36.74% from the current ITCI share price of $57.19. What is ITCI's forecast return on assets (ROA) for 2023-2026?

0001193125-20-288507.txt : 20201109 0001193125-20-288507.hdr.sgml : 20201109 20201109074552 ACCESSION NUMBER: 0001193125-20-288507 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENTIntra-Cellular Therapies, Inc. (ITCI) Stock Price, Quote & News - Stock Analysis NASDAQ: ITCI · IEX Real-Time Price · USD -0.01 (-0.02%) Nov 15, 2023, 4:00 …

Even on an earnings season day when a clutch of companies notched earnings beats, Intra-Cellular Therapies' (ITCI 2.46%) first-quarter beat was notably impressive. Investors liked what they saw in ...The mean of analysts' price targets for Intra-Cellular (ITCI) points to a 41.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement ...ITCI - Intra-Cellular Therapies Inc Stock Price Quote - NASDAQ | Morningstar Intra-Cellular Therapies Inc ITCI Morningstar Rating | Rating as of Sep 7, 2023 Quote Chart Stock Analysis News...The stock is down more than 12% over the past 12 months but up more than 2% so far in 2023. ... (ITCI) Q3 2021 Earnings Call Transcript. Why Intra-Cellular Therapies Was Weak This Week.Market Cap. MediciNova Inc. -2.63%. $90.74M. ITCI | Complete Intra-Cellular Therapies Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial...

ITCI - place your bets With a huge upcoming catalyst - CAPLYTA PDUFA due December 17th, 2021, it will make or break this stock - with an approval from the FDA, I expect pt of around 57, with possibility to hit all-time high within a year from CAPLYTA launch. There is however always a possibility of CRL from the FDA, if th With a huge …

Earnings announcement* for ITCI: Nov 08, 2022. Intra-Cellular Therapies Inc. is estimated to report earnings on 11/08/2022. The upcoming earnings date is derived from an algorithm based on a ...

CAPLYTA is a prescription medication used in adults for the treatment of depressive episodes associated with bipolar I or bipolar II disorder (bipolar depression). CAPLYTA can be taken alone or with the medicines lithium or valproate for bipolar depression. It is not known if CAPLYTA is safe and effective in children.Intra-Cellular Therapies Inc. research and ratings by Barron's. View ITCI revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.Zacks Investment Research is releasing its prediction for ITCI based on the 1-3 month trading system that more than doubles the S&P 500. Click here - the ITCI analysis is free ». Price. 2021 ...Intra-Cellular Therapeutics ITCI is a biopharma company focused on discovering, ... and minimal competition in its target market is likely to keep the stock afloat in the long term.ITCI - Free Report) shares were up 2% on May 5, after the company reported better-than-expected first-quarter 2023 results on May 4. ITCI incurred a loss of 46 cents per share in the reported ...View Valuation. Research Intra-Cellular Therapies' (Nasdaq:ITCI) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, …

Intra-Cellular (ITCI) Depression Drug Meets Study Goal, Stock Up Zacks - Wed Mar 29, 11:27AM CDT . Intra-Cellular Therapeutics (ITCI) announces positive top-line data from its phase III study evaluating lumateperone for the treatment of depression. Stock surges 16% following the news. Oct 26, 2023 · Intra-Cellular Therapies Inc’s trailing 12-month revenue is $365.8 million with a -50.4% profit margin. Year-over-year quarterly sales growth most recently was 99.3%. Analysts expect adjusted earnings to reach $-2.089 per share for the current fiscal year. Intra-Cellular Therapies Inc does not currently pay a dividend. Intra-Cellular Therapies (ITCI Quick Quote ITCI - Free Report) shares soared 16.4% in the last trading session to close at $55.73.The move was backed by solid volume with far more shares changing ...Intra-Cellular Therapies (ITCI) Stock Forecast, Price Targets and ...May 10, 2022 · Intra-Cellular's net loss deepened to $72.1 million ($0.78 per share), from first quarter 2021's $52.7 million deficit. However, analysts -- and likely investors -- had been bracing for worse ... Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting ...Nov. 08. CI. RBC Trims Price Target on Intra-Cellular Therapies to $76 From $77, Keeps Outperform Rating. Nov. 03. MT. Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Reports Q3 Revenue $126.2M. Nov. 02. MT. Transcript : Intra-Cellular Therapies, Inc., Q3 2023 Earnings Call, Nov 02, 2023.

ITCI 4.98%. 58. See ITCI Report. Overall market sentiment has been high on Intra-Cellular Therapies Inc ( ITCI) stock lately. ITCI receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator. Intra-Cellular Therapies Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ITCI!Thank you for your interest in Intra-Cellular Therapies. For more information or to apply to our open positions, please visit our job postings on LinkedIn or send your resume to hr@ itci-inc.com. For Regional Business Manager (field sales leadership) or Neuroscience Sales Specialist roles, please visit the postings our field sales staffing ...

A high-level overview of Intra-Cellular Therapies, Inc. (ITCI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Disruption hit MTR services to Hong Kong’s airport for about an hour on Sunday, because of a fault with the baggage handling system at Airport station. Services were back to normal by 1.25pm. The total journey time on the Airport Express from Hong Kong station to AsiaWorld-Expo station was extended by five to 10 minutes, according to …View the latest Intra-Cellular Therapies Inc. (ITCI) stock price, news, historical charts, analyst ratings and financial information from WSJ. Nov 27, 2022 · Headquartered in Chelmsford, Massachusetts, Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) is a sample exploration and management solutions provider for the life science market. On November 23, 2022 ... Stock Price Forecast. According to 8 stock analysts, the average 12-month stock price forecast for ITCI stock stock is $78.5, which predicts an increase of 34.05%. The lowest target is $62 and the highest is $101. On average, analysts rate ITCI stock stock as a strong buy.ITCI stock shot up to approximately $55 per share after the success of study 403. There is some overhead supply to work through to reach new all-time highs and continued strong sales momentum and ...Find the latest dividend history for Intra-Cellular Therapies Inc. Common Stock (ITCI) at Nasdaq.com.Nov 20, 2023 · Shares of ITCI responded in kind, rallying 16% in the subsequent trading session and ultimately 40% higher to an all-time high of $67.05 in June 2023, suggesting peak sales of $1.75 billion to $2. ...

Mar 28, 2023 · 04:20 PM ET 03/28/2023. Intra-Cellular Therapies ( ITCI) said Tuesday that its depression treatment succeeded in a key study, and ITCI stock broke definitively above its 200-day line for the first ...

0001193125-20-135603.txt : 20200507 0001193125-20-135603.hdr.sgml : 20200507 20200507073227 ACCESSION NUMBER: 0001193125-20-135603 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT

Mar 6, 2023 · Read why ITCI stock is a Hold. Intra-Cellular Therapeutics develops small molecule drugs targeting the CNS for neuropsychiatric and neurological disorders. Read why ITCI stock is a Hold. Track Intra-Cellular Therapies Inc (ITCI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsIntra-Cellular Therapies, Inc. (ITCI) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 62.84 +1.47 (+2.40%) At close: 04:00PM EST. 60.44 -2.40 (-3.82%) After hours:...Intra-Cellular Therapies, Inc. (ITCI) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 62.84 +1.47 (+2.40%) At close: 04:00PM EST. 60.44 -2.40 (-3.82%) After hours:...2 thg 11, 2023 ... ... stock report on ITCI at https://www.zacks.com/ap/ITCI. Advertisement. Sign up for the Daily Brief. Our free, fast, and fun briefing on the ...May 8, 2023 · ITCI stock rallied 2.2% Friday. Inspire Medical Systems ( INSP ) posted a weekly gain despite three losing days, gaining 3.8% Friday. INSP shares formed a handle and flirted with the 277.28 buy ... May 10, 2022 · Intra-Cellular's net loss deepened to $72.1 million ($0.78 per share), from first quarter 2021's $52.7 million deficit. However, analysts -- and likely investors -- had been bracing for worse ... Intra-Cellular Therapies Inc. 430 East 29th Street. Suite 900. New York, New York 10016. Phone 1 464 440-9333. Industry Pharmaceuticals. Sector Health Care/Life Sciences. Fiscal Year-end 12/2023 ...Stock analysis for Intra-Cellular Therapies Inc (ITCI:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Chg %. Market Cap. MediciNova Inc. -2.63%. $90.74M. ITCI | Complete Intra-Cellular Therapies Inc. stock news by MarketWatch. View real-time stock prices and stock …

ITCI - place your bets With a huge upcoming catalyst - CAPLYTA PDUFA due December 17th, 2021, it will make or break this stock - with an approval from the FDA, I expect pt of around 57, with possibility to hit all-time high within a year from CAPLYTA launch.Real time Intra-Cellular Therapies (ITCI) stock price quote, stock graph, news & analysis.Find the latest dividend history for Intra-Cellular Therapies Inc. Common Stock (ITCI) at Nasdaq.com.Instagram:https://instagram. is et a good stock to buymargin on webull1964 kennedy half valuegrace kennedy Intra-Cellular (ITCI) delivered earnings and revenue surprises of 26.98% and 3.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?Get the latest stock price for Intra-Cellular Therapies Inc. (ITCI:US), plus the latest news, recent trades, charting, insider activity, ... best technology stocksbest stocks on cash app Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t... currency trading robots A high-level overview of Intra-Cellular Therapies, Inc. (ITCI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …Intra-Cellular Therapies, Inc. (ITCI) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 62.84 +1.47 (+2.40%) At close: 04:00PM EST. 60.44 -2.40 (-3.82%) After hours:...